Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04291625
Other study ID # 19519OPHT38
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date February 15, 2020

Study information

Verified date February 2020
Source Menoufia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective non-randomized study to evaluate the recent intraoperative lagophthalmos formula method for levator resection in determining postoperative eyelid height in congenital ptosis on Egyptian children. included 20 eyelids from 17 Egyptian children with congenital ptosis with levator function of 4mm or better, they underwent levator muscle resection guided by the recent intraoperative lagophthalmos formula


Description:

This is a prospective non-randomized study to evaluate the recent intraoperative lagophthalmos formula method for levator resection in determining postoperative eyelid height in congenital ptosis on Egyptian children. The study included 20 eyelids of 17 Egyptian children with congenital ptosis with levator function of 4mm or better, they underwent levator muscle resection guided by the recent intraoperative lagophthalmos formula.

Preoperative MRD 1 (Margin-to-reflex distance 1) and levator function were measured, then intraoperative palpebral fissure opening was determined from formula: Intraoperative lagophthalmos=9.08 - 0.48×Preoperative MRD1 - 0.26× Levator function. Postoperative MRD 1 was measured after 1 day, 1week,1month, 3 months and 6 months .Success was defined as postoperative MRD 1 ≥ 3 mm and difference between both eyelids height ≤ 1 mm at 6 months.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date February 15, 2020
Est. primary completion date January 1, 2020
Accepts healthy volunteers No
Gender All
Age group 3 Years to 15 Years
Eligibility Inclusion Criteria:

- simple congenital ptosis (any degree) with levator function of 4mm or more

Exclusion Criteria:

- levator function less than 4mm

- a history of previous ptosis surgery

- other accompanying congenital diseases, such as blepharophimosis, congenital fibrosis of the extraocular muscles, Marcus Gunn (jaw-winking) syndrome, double elevator palsy and congenital third nerve palsy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Levator muscle resection
Surgery was performed under general anaesthesia. Two milliliters of 2% lidocaine with 1:100 000 epinephrine is injected subcutaneously. After the upper eyelid incision at the desired crease line, the orbital septum was opened and the preaponeurotic fat was identified and dissected off the levator aponeurosis. The aponeurosis was disinserted from the tarsus, and the complex of levator aponeurosis and Muller muscle was dissected free from the conjunctiva. The desired eyelid height was determined from the proposed formula. Satisfactory Intraoperative lagophthalmos was defined as a difference of less than 1 mm between recommended by the formula and actual intraoperative lagophthalmos. After permanent fixation, a caliper was used for precise measurement of lagophthalmos in a supine position. Additional sutures were placed on the medial and lateral sides for satisfactory eyelid contour. The redundant levator complex was excised. Eyelid crease was made by placing three interrupted sutures

Locations

Country Name City State
Egypt Ophthalmology Department, Menoufia University Hospital Shibin Al Kawm Menoufia

Sponsors (1)

Lead Sponsor Collaborator
Menoufia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Chick the validity of Lagophthalmos formula for Egyptian children with congenital ptosis We apply the following formula:
Intraoperative lagophthalmos=9.08 - 0.48×Preoperative MRD1 - 0.26×Levator function.
We tried to achieve the calculated lagophthalmos by the formula intraoperatively
6 months
See also
  Status Clinical Trial Phase
Completed NCT04585217 - A Comparison of the Effect of Suture Material on Blepharoplasty Incision N/A
Recruiting NCT05480098 - Brimonidine for Intraoperative Hemostasis Phase 4
Recruiting NCT05890027 - Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation Phase 4
Completed NCT06047418 - Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation
Completed NCT04831047 - The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance Phase 4
Active, not recruiting NCT04678115 - Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis N/A
Not yet recruiting NCT04235803 - Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery N/A
Completed NCT05770973 - Effect of Eyelid Patching After Ptosis Surgery N/A
Completed NCT00753831 - Efficacy of Aurosling in Frontalis Sling Suspension Surgery Phase 4
Enrolling by invitation NCT03916107 - Comparison of Different Surgical Treatments for Severe Ptosis Correction N/A
Completed NCT03818204 - Clinical Trial to Improve the Magnetic Levator Prosthesis N/A
Recruiting NCT05750251 - Effect of Upper Eyelid Surgeries on Corneal Characteristics
Not yet recruiting NCT03392272 - Modified Müller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue N/A
Recruiting NCT01616108 - Bupivacaine Injection of Eye Muscles to Treat Strabismus Phase 2/Phase 3